Stay updated on Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial
Sign up to get notified when there's something new on the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page.

Latest updates to the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 and removed a general funding/status notice; these are minor maintenance updates to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check21 days agoChange DetectedAdded a government-funding-status notice and a new system revision tag (Revision: v3.4.1); the prior revision tag (Revision: v3.4.0) was removed.SummaryDifference0.7%

- Check28 days agoChange DetectedThe history page now includes a glossary toggle and color-coded highlights for additions and deletions (green and red). The latest revision is shown as v3.4.0, replacing the previous v3.3.4.SummaryDifference0.8%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the Record History, a minor update to the page's version log that does not affect trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedThe record history now includes Revision: v3.3.3, and the footer no longer displays HHS Vulnerability Disclosure or Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedNew revision entry v3.3.2 appears in the record history, and the v3.2.0 entry is removed.SummaryDifference0.1%

Stay in the know with updates to Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page.